Phase 1 Study in Healthy Subjects to Evaluate the Effect of IPI-145 on the Pharmacokinetics of Midazolam
Clinical trial NCT01925911 · COMPLETED
Trial details
- NCT number
- NCT01925911
- Sponsor
- SecuraBio
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-09-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.